30-Minute infusion of isatuximab in patients with newly diagnosed multiple myeloma: Results of a Phase 1b study analysis

Affiliations

• ¹ Servicio de Hematología y Hemoterapia, Hospital Universitario Marqués de Valdecilla University Hospital (IDIVAL) Universidad de Cantabria Santander Spain.
• ² Service d'Hématologie, CHU de Toulouse, IUCT-O Université de Toulouse Toulouse France.
• ³ Department of Hematology University of Nantes Nantes France.
• ⁴ Department of Hematology University Hospital of Salamanca and Cancer Research Center (IBMCC-CSICUSAL) Salamanca Spain.
• ⁵ Department of Onco-Ematologia e Myeloma Multiplo, SSD Clinical Trials AOU Città della Salute e della Scienza di Torino Italy.
• ⁶ Department of Hematology Hospital Universitario 12 de Octubre, CNIO, Universidad, Complutense de Madrid Spain.
• ⁷ Service d'Hématologie Clinique, Hôpital Lyon Sud Hospices Civils de Lyon Pierre-Bénite France.
• ⁸ Department of Hematology and Oncology University of Leipzig Leipzig Germany.
• ⁹ Research and Development, Sanofi Vitry-sur-Seine France.
• ¹⁰ Research and Development, Sanofi Bejing China.
• ¹¹ Department of Clinical and Translational Medicine University of Navarra (CCUN), Center for Applied Medical Research (CIMA), IDISNA, CIBERONC Pamplona Spain.